ORP-101

ORP-101 is a new chemical entity designed with intent to create a large stable molecule and to confer partial μ agonist and full κ-antagonist receptor pharmacology.

O(C)[C@@]12[C@]3([C@]45[C@@]([C@](N(CC6CC6)CC4)(CC7=C5C(O3)=C(OCCOC8=C9C=%10[C@@]%11%12[C@@](O9)([C@]%13(OC)[C@@]([C@]([C@](C)(C)C)(C)O)(C[C@@]%11([C@@](CC%10C=C8)(N(CC%14CC%14)CC%12)[H])CC%13)[H])[H])C=C7)[H])(C[C@@]1([C@]([C@](C)(C)C)(C)O)[H])CC2)[H]